New funding

The lab has received funding from the Terri Brodeur Breast Cancer Foundation. This will enable really critical work to study the pleiotropic effects of TAM receptors and develop rationally designed inhibitors. Ultimately, this work aims to also help us determine which patients will benefit from these therapies.